leiomyoma
Information
- Disease name
- leiomyoma
- Disease ID
- DOID:127
- Description
- "A cell type benign neoplasm that is a benign tumor of smooth muscle cells." [url:http\://en.wikipedia.org/wiki/Cancer, url:http\://en.wikipedia.org/wiki/Leiomyoma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04655144 | Active, not recruiting | Phase 3 | Dexamethasone for Post Uterine Artery Embolization Pain | January 25, 2021 | December 15, 2024 |
| NCT03323905 | Active, not recruiting | N/A | Single Arm Study Using the Symphony -- MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas | November 16, 2017 | June 1, 2024 |
| NCT00087841 | Completed | Phase 2 | Self-Hypnotic Relaxation Therapy During Invasive Procedures | April 2002 | November 2006 |
| NCT00100191 | Completed | Phase 3 | Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids | February 2002 | April 2006 |
| NCT00131365 | Completed | N/A | Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine Fibroids | January 2006 | February 2009 |
| NCT00133705 | Completed | Phase 3 | Trial of Mifepristone for Fibroids | July 2003 | June 2010 |
| NCT00150644 | Completed | Phase 2 | A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy | July 2003 | May 2005 |
| NCT00152256 | Completed | Phase 3 | A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids | September 2003 | February 2005 |
| NCT00152269 | Completed | Phase 3 | Treatment of Uterine Fibroids With Asoprisnil(J867) | July 2002 | January 2005 |
| NCT04996498 | Completed | N/A | Hemostatic Effect of Intrauterine Instillation of Oxytocin in Hysteroscopic Myomectomy | April 15, 2021 | October 1, 2022 |
| NCT00156156 | Completed | Phase 3 | Study of Asoprisnil in the Treatment of Uterine Fibroids. | November 2004 | February 2007 |
| NCT00156182 | Completed | Phase 2 | A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. | April 2001 | December 2001 |
| NCT00156195 | Completed | Phase 3 | Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids | September 2003 | January 2007 |
| NCT00156208 | Completed | Phase 3 | Safety of Treatment of Uterine Fibroids With Asoprisnil | April 2004 | December 2006 |
| NCT00160381 | Completed | Phase 3 | A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids | September 2002 | January 2005 |
| NCT00160459 | Completed | Phase 2 | A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids | May 2000 | July 2001 |
| NCT00290251 | Completed | Phase 2 | Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914 | February 2006 | August 2010 |
| NCT04030182 | Completed | Vitamin D Deficit in Women With Uterine Fibroids | December 1, 2019 | October 9, 2021 | |
| NCT00361036 | Completed | Phase 1 | Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent | August 2006 | March 2010 |
| NCT03815344 | Completed | Phase 4 | Combined Vaginal Misoprostol and Perivascular Vasopressin | April 26, 2017 | June 30, 2019 |
| NCT03427671 | Completed | N/A | OCL 500 Treatment of Women With Symptomatic Uterine Fibroids | January 17, 2018 | September 3, 2019 |
| NCT00628901 | Completed | Phase 4 | A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) | January 2006 | January 2011 |
| NCT03420248 | Completed | N/A | Comparison of Pain of Two Different Methods in Uterine Artery Embolization | April 19, 2018 | May 8, 2019 |
| NCT00731341 | Completed | N/A | Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata | July 2008 | February 2009 |
| NCT00746031 | Completed | Phase 4 | Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids | December 2008 | September 2010 |
| NCT02270255 | Completed | Phase 2 | Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization | April 2015 | November 1, 2017 |
| NCT00044876 | Completed | Phase 2 | Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist | September 2, 2002 | October 1, 2015 |
| NCT02465814 | Completed | Phase 2 | Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids | June 2015 | October 2016 |
| NCT03092999 | Completed | Phase 1 | Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan) | March 28, 2017 | July 17, 2017 |
| NCT00891657 | Completed | N/A | Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy | November 2008 | May 2009 |
| NCT01123603 | Completed | Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine Leiomyomata | May 2010 | June 2014 | |
| NCT02997787 | Completed | New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma | January 2016 | November 2016 | |
| NCT02889848 | Completed | Phase 1 | Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids) | October 27, 2016 | November 15, 2018 |
| NCT01530802 | Completed | N/A | Temporary Clipping of the Uterine Arteries During Laparoscopic Myomectomy | January 2007 | December 2009 |
| NCT02777203 | Completed | N/A | Power Morcellation Systems for Laparoscopic Hysterectomy and Myomectomy | May 2016 | June 30, 2019 |
| NCT02580578 | Completed | A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fibroids | July 31, 2015 | January 31, 2020 | |
| NCT02577055 | Completed | N/A | Fertility After Myomectomy Versus Uterine Artery Embolization for Symptomatic Uterine Fibroids | April 2016 | October 16, 2019 |
| NCT01793584 | Completed | N/A | Surgical Success After Laparoscopic vs Abdominal Hysterectomy | February 2013 | December 31, 2016 |
| NCT01816815 | Completed | Phase 1 | Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670 | November 2011 | January 2013 |
| NCT02470741 | Completed | Phase 4 | Pilot of Letrozole for Uterine Myomas | July 2015 | December 2017 |
| NCT02061657 | Completed | Phase 3 | Impact of Misoprostol on Blood Loss In Myomectomy Operations | June 2013 | July 2014 |
| NCT02123069 | Completed | Vascular Function and Uterine Fibroids | April 2013 | March 1, 2018 | |
| NCT02131662 | Completed | Phase 2 | Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, Jap | May 15, 2014 | May 4, 2016 |
| NCT02147158 | Completed | Phase 3 | A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas | January 29, 2014 | November 24, 2016 |
| NCT02147197 | Completed | Phase 3 | A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas | March 31, 2014 | March 29, 2016 |
| NCT02189083 | Completed | Phase 3 | Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine Fibroids | May 2014 | February 2016 |
| NCT03369600 | Enrolling by invitation | N/A | Characterisation of Uterine Fibroid Tissue Stiffness | August 17, 2018 | July 31, 2025 |
| NCT06143631 | Recruiting | Phase 4 | Prescription of Letrozole for Uterine Myoma | June 14, 2024 | April 30, 2027 |
| NCT03400826 | Recruiting | Phase 2 | Effects of Simvastatin on Uterine Leiomyoma Size | August 20, 2018 | December 1, 2024 |
| NCT04145518 | Recruiting | Phase 4 | Mechanistic Characterization of Uterine Pain | October 25, 2019 | September 1, 2024 |
| NCT05474794 | Recruiting | N/A | Detective Flow Imaging Endoscopic Ultrasonography in Subepithelial Lesions | July 20, 2022 | June 20, 2024 |
| NCT05538689 | Recruiting | Phase 4 | Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL) | November 20, 2022 | April 2026 |
| NCT06135870 | Recruiting | Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study) | November 1, 2023 | December 31, 2027 | |
| NCT02940041 | Terminated | Concordance Between Sonography Amd MRI for Presurgical Diagnosis of Uterine Mesenchymal Malignant Tumors | September 2016 | September 2021 | |
| NCT01226290 | Terminated | N/A | Fibroid Ablation Study | January 2011 | March 2014 |
| NCT03342859 | Terminated | Phase 1 | Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned | November 16, 2017 | January 13, 2020 |
| NCT00710346 | Terminated | Establishment of Fibroid Tissue Bank | June 30, 2008 | September 1, 2016 | |
| NCT00001850 | Terminated | Evaluation of Women With Endocrine and Reproductive-Related Conditions | May 10, 1999 | May 23, 2023 | |
| NCT00219778 | Terminated | Phase 2 | A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas | December 2004 | February 2010 |
| NCT01998854 | Terminated | Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation | February 2013 | January 2015 | |
| NCT01581905 | Terminated | N/A | Study of Conventional Laparoscopic Hysterectomy Versus Robot-Assisted Laparoscopic Hysterectomy at a Teaching Institution | March 2012 | June 2013 |
| NCT01539187 | Terminated | N/A | Fibroid Ablation Study - Large Fibroids | June 2012 | June 2014 |
| NCT01311869 | Terminated | Phase 2 | Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids | December 2010 | September 2011 |
| NCT03550703 | Unknown status | Phase 2 | Open Label Immunotherapy of Myoma | June 1, 2018 | December 31, 2019 |
| NCT00299481 | Unknown status | Tissue Bank of Biological Specimens From Patients With Gynecologic Disease | March 2006 | January 2011 | |
| NCT00155870 | Unknown status | Health-Related QoL Among Women Receiving Hysterectomy in NTUH | June 2005 | June 2005 | |
| NCT04172272 | Unknown status | N/A | The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures | September 24, 2019 | December 31, 2021 |
| NCT00574418 | Unknown status | Phase 1 | Far Infrared Radiation Treatment for Uterine Fibroids | January 2006 | September 2008 |
| NCT00390494 | Unknown status | Questionnaire Study to Assess Quality of Life After Treatment of Fibroids | December 2005 | December 2010 | |
| NCT00821275 | Unknown status | Phase 2/Phase 3 | Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma | January 2008 | December 2018 |
| NCT04214457 | Unknown status | Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas | September 20, 2019 | July 2022 | |
| NCT05151393 | Unknown status | Correlation Between Serum Vitamin D3 and Incidence of Uterine Leiomyoma | December 1, 2021 | February 15, 2022 | |
| NCT01768104 | Unknown status | N/A | ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors | December 2011 | December 2013 |
| NCT00827645 | Withdrawn | Uterine Artery Embolization and Pelvic Floor Symptoms | January 1, 2009 | January 1, 2013 | |
| NCT00768742 | Withdrawn | N/A | Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study | September 2008 | November 2010 |
- Disase is a (Disease Ontology)
- DOID:0060084
- Cross Reference ID (Disease Ontology)
- ICDO:8890/0
- Cross Reference ID (Disease Ontology)
- MESH:D007889
- Cross Reference ID (Disease Ontology)
- NCI:C3157
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:1162890002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0023267
- Exact Synonym (Disease Ontology)
- leiomyomatous neoplasm
- Exact Synonym (Disease Ontology)
- leiomyomatous tumor
- MeSH unique ID (MeSH (Medical Subject Headings))
- D007889